| P2093 | author name string | Zhi-Dong Wang | |
| | Qing-Xin Zhou | |
| | Yun-Fu Cui | |
| | Chun-Long Li | |
| | Xing-Ming Jiang | |
| P2860 | cites work | The basics of epithelial-mesenchymal transition | Q24652992 |
| | Suppressor of cytokine signaling-3 antagonizes cAMP effects on proliferation and apoptosis and is expressed in human prostate cancer | Q24677026 |
| | SOCS, inflammation, and cancer | Q26991808 |
| | Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain | Q28140535 |
| | SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer | Q33715489 |
| | Cholangiocarcinoma: Current concepts and insights | Q33965702 |
| | Serum and bile markers for cholangiocarcinoma | Q33979059 |
| | Loss of expression and function of SOCS3 is an early event in HNSCC: altered subcellular localization as a possible mechanism involved in proliferation, migration and invasion | Q34428326 |
| | Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution | Q34578979 |
| | Pathogenesis, diagnosis, and management of cholangiocarcinoma | Q34656747 |
| | Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes | Q34881846 |
| | Metformin inhibits the IL-6-induced epithelial-mesenchymal transition and lung adenocarcinoma growth and metastasis | Q35161856 |
| | Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing | Q36388792 |
| | SOCS regulation of the JAK/STAT signalling pathway | Q37003892 |
| | Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas. | Q37080992 |
| | Inflammation and EMT: an alliance towards organ fibrosis and cancer progression | Q37668231 |
| | Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage | Q37845554 |
| | Current therapy of hilar cholangiocarcinoma | Q37976498 |
| | Cancer-related inflammation and treatment effectiveness | Q38256601 |
| | Role of crosstalk between interleukin-6 and transforming growth factor-beta 1 in epithelial-mesenchymal transition and chemoresistance in biliary tract cancer | Q39214336 |
| | IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway | Q39462532 |
| | Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. | Q39828317 |
| | Expression of SOCS1 and SOCS3 genes is differentially regulated in breast cancer cells in response to proinflammatory cytokine and growth factor signals. | Q40227613 |
| | Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells | Q40345898 |
| | Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma | Q40399429 |
| | Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor beta1, and activin A: comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cel | Q40871475 |
| | Inflammation and cancer: IL-6 and STAT3 complete the link. | Q41957513 |
| | IL-6/STAT3/TFF3 signaling regulates human biliary epithelial cell migration and wound healing in vitro | Q46752331 |
| | Human biliary epithelial cells secrete and respond to cytokines and hepatocyte growth factors in vitro: interleukin-6, hepatocyte growth factor and epidermal growth factor promote DNA synthesis in vitro | Q72094183 |
| | SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition | Q80353124 |
| P433 | issue | 4 | |
| P921 | main subject | cholangiocarcinoma | Q124292 |
| P304 | page(s) | 105 | |
| P577 | publication date | 2015-03-06 | |
| P1433 | published in | Medical Oncology | Q2152666 |
| P1476 | title | Enhanced expression of suppresser of cytokine signaling 3 inhibits the IL-6-induced epithelial-to-mesenchymal transition and cholangiocarcinoma cell metastasis | |
| P478 | volume | 32 | |